BC
MEDP icon

Burleson & Co’s Medpace MEDP Stock Holding History

Burleson & Co’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$7.43K Hold
35
– – ﹤0.01% 287
2022
Q3 		$6K Hold
35
– – ﹤0.01% 308
2022
Q2 		$5K Hold
35
– – ﹤0.01% 296
2022
Q1 		$6K Hold
35
– – ﹤0.01% 293
2021
Q4 		$8K Hold
35
– – ﹤0.01% 276
2021
Q3 		$7K Buy
+35
New +$6.38K ﹤0.01% 272

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Burleson & Co's MEDP Position: Q4 2022 in Review

Burleson & Co held its Medpace (MEDP) position steady in Q4 2022 at 35 shares worth $7.43K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Burleson & Co first reported a position in MEDP in Q3 2021 and has held it in 6 quarters since. The position peaked at $8K in Q4 2021. 422 funds tracked by Wall St. Rank hold MEDP as of Q4 2022.

  • Burleson & Co held 35 shares of Medpace worth $7.43K as of Q4 2022.
  • Burleson & Co left its Medpace share count unchanged in Q4 2022.
  • Medpace made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #287 holding.
  • Burleson & Co first reported a position in Medpace in Q3 2021 and has held it in 6 quarters since.
  • Burleson & Co's Medpace position peaked at $8K in Q4 2021.
  • 422 funds tracked by Wall St. Rank held Medpace as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.